Adiponectin, an adipose-specific protein, has gained much attention due to its effect on glucose homeostasis and regulation of energy metabolism, making it a candidate link between obesity and insulin resistance [1], and a potential therapeutic pathway. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.